New therapeutic potential for psychoactive natural products
- PMID: 20024092
- DOI: 10.1039/b912196j
New therapeutic potential for psychoactive natural products
Abstract
Much of our knowledge in neuroscience was discovered through the study of mind-altering natural products. However, although much has been learned about human physiology and basic biological processes, the underlying causes of CNS disorders and other disease states are still elusive. Based on its main past successes, the continued study of mind-altering compounds promises to yield novel agents that may be developed into medications and to identify new targets for the treatment of diseases. This Highlight describes the history of investigations into several classes of mind-altering natural products and relates recent and potential therapeutic uses for these agents.
Similar articles
-
Natural products as tools for neuroscience: discovery and development of novel agents to treat drug abuse.J Nat Prod. 2009 Mar 27;72(3):581-7. doi: 10.1021/np8005748. J Nat Prod. 2009. PMID: 19099466 Free PMC article. Review.
-
Multi-target compounds acting in the central nervous system designed from natural products.Curr Med Chem. 2013;20(13):1673-85. doi: 10.2174/0929867311320130007. Curr Med Chem. 2013. PMID: 23410166 Review.
-
Evaluating Marine Cyanobacteria as a Source for CNS Receptor Ligands.Molecules. 2018 Oct 17;23(10):2665. doi: 10.3390/molecules23102665. Molecules. 2018. PMID: 30336553 Free PMC article.
-
The re-emergence of natural products for drug discovery in the genomics era.Nat Rev Drug Discov. 2015 Feb;14(2):111-29. doi: 10.1038/nrd4510. Epub 2015 Jan 23. Nat Rev Drug Discov. 2015. PMID: 25614221 Review.
-
Natural products as a source of Alzheimer's drug leads.Nat Prod Rep. 2011 Jan;28(1):48-77. doi: 10.1039/c0np00027b. Epub 2010 Nov 12. Nat Prod Rep. 2011. PMID: 21072430 Free PMC article. Review.
Cited by
-
Identification and characterization of plant-derived alkaloids, corydine and corydaline, as novel mu opioid receptor agonists.Sci Rep. 2020 Aug 14;10(1):13804. doi: 10.1038/s41598-020-70493-1. Sci Rep. 2020. PMID: 32796875 Free PMC article.
-
A single injection of a novel κ opioid receptor agonist salvinorin A attenuates the expression of cocaine-induced behavioral sensitization in rats.Behav Pharmacol. 2012 Apr;23(2):162-70. doi: 10.1097/FBP.0b013e3283512c1e. Behav Pharmacol. 2012. PMID: 22293826 Free PMC article.
-
Semisynthetic neoclerodanes as kappa opioid receptor probes.Bioorg Med Chem. 2012 May 1;20(9):3100-10. doi: 10.1016/j.bmc.2012.02.040. Epub 2012 Mar 1. Bioorg Med Chem. 2012. PMID: 22464684 Free PMC article.
-
Pharmacology and anti-addiction effects of the novel κ opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin A.Br J Pharmacol. 2015 Jan;172(2):515-31. doi: 10.1111/bph.12692. Epub 2014 Jul 1. Br J Pharmacol. 2015. PMID: 24641310 Free PMC article.
-
Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents.Molecules. 2018 Oct 11;23(10):2602. doi: 10.3390/molecules23102602. Molecules. 2018. PMID: 30314288 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous